BERGEN MEDICAL PRODUCTS, INC. raises $1.825MM in SERIES A financing to advance innovative surgical wound closure medical devices.

Share Article

BERGEN MEDICAL PRODUCTS, INC., a medical device manufacturing company developing novel and innovative surgical medical device products partners with Golden Seeds Fund 2 to completed a $1.825 million Preferred Series A financing.

BERGEN MEDICAL PRODUCTS, INC., a medical device manufacturing company developing novel and innovative surgical medical device products, has completed a $1.825 million Preferred Series A financing. It will use funds raised from this round to bring one or more of its products to market. The round was led by Golden Seeds, one of the nation’s largest angel investing groups, and was syndicated with Jumpstart New Jersey Angel Network.

“We are very pleased to welcome Bergen Medical to the portfolio of investments made by the Golden Seeds network and Golden Seeds Fund 2. Bergen Medical’s disruptive technology and business strategy are well aligned with our mission to back women-led businesses in the early stages of their development," said Kathryn Swintek, Board Member & General Partner, Golden Seeds Fund 2.

“This financing increases our investor base and further expands our manufacturing and research capabilities to bring innovative wound closure medical device products to market that help improve clinical outcomes while still significantly lowering costs to hospitals,” said Bergen Medical’s President and CEO, Robert Laudadio. “We are excited to partner with our lead investor Golden Seeds, as well as members of Jumpstart New Jersey Angel Network in supporting our vision for improving the lives of patients while helping hospitals control costs.”

“The medical devices Bergen Medical Products, Inc. are developing represent new approaches that have the potential to make a major impact on the ability to help reduce infections and improve surgical wound closure outcomes,” said Melissa Vinci-Rainis, Vice-President & COO. “There are nearly 80 million procedures performed annually that can use Bergen Medical’s products.”

Funds raised in this round will support the manufacturing capabilities and preclinical work required for the FDA filings, and enable Bergen Medical to further expand into other therapeutic areas.

Bergen Medical Products, Inc. is developing novel medical devices targeting surgeries in the OR and trauma in emergency departments. Bergen Medical has leveraged its extensive industry experience and scientific expertise to design, develop and produce innovative medical devices.

Golden Seeds is one of the largest angel investing groups in the country. With locations in New York, Boston, and San Francisco. Golden Seeds’ 275 members assist in all phases of the investment process, providing resources and expertise.

Jumpstart New Jersey Angel Network is a member-led, angel group of successful serial entrepreneurs, business executives and venture capitalists which actively invests in early-stage technology ventures in the Mid-Atlantic region and beyond. Jumpstart member led investments total over $35 million in over 45 companies.

Share article on social media or email:

View article via:

Pdf Print